EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 1565659)

Published in Br J Pharmacol on November 01, 1998

Authors

S Y James1, E Mercer, M Brady, L Binderup, K W Colston

Author Affiliations

1: Division of Gastroenterology, Endocrinology and Metabolism, St George's Hospital Medical School London.

Articles citing this

Role of vitamin D in uterine fibroid biology. Fertil Steril (2015) 1.44

Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys (2011) 1.28

Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer (2001) 1.16

Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene (2005) 1.12

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br J Cancer (2002) 1.09

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer (2003) 1.08

Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells. J Steroid Biochem Mol Biol (2010) 1.07

1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod (2012) 1.06

(Patho)physiological implications of the novel epithelial Ca2+ channels TRPV5 and TRPV6. Pflugers Arch (2003) 1.03

25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res (2005) 1.01

Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro. Br J Cancer (2000) 1.01

Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev Dermatol (2007) 0.98

The future of vitamin D analogs. Front Physiol (2014) 0.93

Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention. J Steroid Biochem Mol Biol (2012) 0.90

Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle (2013) 0.89

1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. Br J Cancer (2003) 0.86

Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells. J Steroid Biochem Mol Biol (2007) 0.84

The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites. J Steroid Biochem Mol Biol (2013) 0.84

Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer. J Steroid Biochem Mol Biol (2014) 0.83

Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells. Br J Cancer (2001) 0.82

The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line. Virology (2015) 0.76

A xenograft animal model of human arteriovenous malformations. Orphanet J Rare Dis (2013) 0.75

Articles by these authors

Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22

Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage (2001) 12.61

Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med (2001) 6.01

Expression and structure of the human NGF receptor. Cell (1986) 3.82

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA (1999) 2.79

Inflammatory mediators in acute pancreatitis. J Pathol (2000) 2.66

Public-sector patents on human DNA. Nature (1997) 2.63

Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant (1997) 2.39

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33

Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics (1992) 2.21

Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer (2000) 2.12

Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12

Role of penile biopsy in the diagnosis of penile dermatoses. Int J STD AIDS (2010) 2.04

Affinity of calciferol analogues for 25-hydroxycholecalciferol receptors. Clin Sci Mol Med (1974) 1.83

Estimating the bias field of MR images. IEEE Trans Med Imaging (1997) 1.81

Analysis of dynamic MR breast images using a model of contrast enhancement. Med Image Anal (1997) 1.78

The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72

Correction of uneven illumination (vignetting) in digital microscopy images. J Clin Pathol (2003) 1.71

A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. J Hyg (Lond) (1975) 1.67

Breast composition measurements using retrospective standard mammogram form (SMF). Phys Med Biol (2006) 1.63

Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62

Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and results. Arthritis Rheum (2012) 1.58

Topical calcipotriol treatment in advanced breast cancer. Lancet (1991) 1.53

Comparison of mitral valve area results of balloon mitral valvotomy using the Inoue and double balloon techniques. Am J Cardiol (1991) 1.53

Broviac catheter-related Malassezia furfur sepsis in five infants receiving intravenous fat emulsions. J Pediatr (1984) 1.48

Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res (2000) 1.44

Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer (2002) 1.44

Petrol sniffing down the track. Med J Aust (1994) 1.42

Contraception and medical gynaecology for HIV-positive women in a one-stop clinic. Int J STD AIDS (2008) 1.41

Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol (2001) 1.40

Practices surrounding ribavirin administration. Pediatr Nurs (1992) 1.39

Sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2) gene products are regulated post-transcriptionally during rat cardiac development. Cardiovasc Res (1999) 1.37

Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci (2001) 1.35

A nosocomial outbreak of diarrheal disease due to Yersinia enterocolitica serotype 0:5, biotype 1. J Infect Dis (1982) 1.33

Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum (1984) 1.31

Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am Rev Respir Dis (1983) 1.30

Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut (2000) 1.25

Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer (1997) 1.25

Three-dimensional reconstruction of microcalcification clusters from two mammographic views. IEEE Trans Med Imaging (2001) 1.23

Purification and characterization of calmodulin-dependent protein kinase III from rabbit reticulocytes and rat pancreas. J Biol Chem (1993) 1.20

Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol Biomarkers Prev (1999) 1.20

Effect of calcitonin on vitamin D metabolism. Nature (1972) 1.19

A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br J Cancer (1998) 1.19

Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer (2001) 1.16

Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology (1998) 1.14

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection. Eur J Immunol (2001) 1.14

20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res (1995) 1.11

Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer. BJU Int (2002) 1.10

Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. Contraception (2001) 1.10

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br J Cancer (2002) 1.09

A representation for mammographic image processing. Med Image Anal (1996) 1.09

T-lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia. Ann Intern Med (1983) 1.08

EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol (1992) 1.08

Regulation of vitamin-D metabolism without parathyroid hormone. Lancet (1973) 1.07

The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells. Br J Cancer (2002) 1.05

Effect of prolactin on vitamin D metabolism. Mol Cell Endocrinol (1976) 1.05

The regulation of vitamin D metabolism. Nature (1973) 1.04

Detection of osteomalacia in British Asians: a comparison of clinical score with biochemical measurements. Clin Sci (Lond) (1990) 1.04

Health care policy for aboriginal Australians: the relevance of the American Indian experience. Aust J Public Health (1995) 1.03

Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest (1992) 1.03

The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res (2000) 1.03

Regulation of vitamin D metabolism: factors influencing the rate of formation of 1,25-dihydroxycholecalciferol by kidney homogenates. Biochem J (1973) 1.02

Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos Int (2012) 1.02

Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro. Br J Cancer (2000) 1.01

Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res (1996) 1.01

Blunted seasonal variation in serum 25-hydroxy vitamin D and increased risk of osteomalacia in vegetarian London Asians. Eur J Clin Nutr (1992) 1.00

Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol (1996) 1.00

Comparing measurements of breast density. Phys Med Biol (2007) 1.00

Preferential binding of collagenase to alpha 2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases. FEBS Lett (1986) 0.99

Characterization of a cytoplasmic receptor-like binder for 1 alpha, 25-dihydroxycholecalciferol in rat intestinal mucosa. J Biol Chem (1979) 0.99

Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Des (2000) 0.98

Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo. Breast Cancer Res Treat (1999) 0.98

CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo. Cancer Res (1999) 0.97

Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells. J Endocrinol (1994) 0.95

A comparison of some anthropometric parameters between an Italian and a UK population: "proof of principle" of a European project using MammoGrid. Clin Radiol (2007) 0.95

Segmenting time-lapse phase contrast images of adjacent NIH 3T3 cells. J Microsc (2012) 0.95

The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene (1995) 0.94

Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol (1999) 0.94

Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa. Eur Respir J (2011) 0.94

Perioperative brain shift and deep brain stimulating electrode deformation analysis: implications for rigid and non-rigid devices. Ann Biomed Eng (2012) 0.93

Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J Endocrinol (1997) 0.93

Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells. Eur J Cancer (1999) 0.93

The activation of latent pig synovial collagenase. Biochim Biophys Acta (1981) 0.92

A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters. J Hyg (Lond) (1975) 0.92

1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis (1994) 0.92

Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitr Mol Toxicol (2000) 0.92

Rat kidney carboxylesterase. Cloning, sequencing, cellular localization, and relationship to rat liver hydrolase. J Biol Chem (1994) 0.92

Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol (1995) 0.92

Self-fulfilling effects of stigmatizing information on children's social interactions. J Pers Soc Psychol (1992) 0.92

EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol (1993) 0.91

Examination of structurally selective derivatization of vitamin D(3) analogues by electrospray mass spectrometry. J Mass Spectrom (2001) 0.91

MammoGrid--a prototype distributed mammographic database for Europe. Clin Radiol (2007) 0.90

Alkaline phosphatase: a possible transport protein for inorganic phosphate. Biochem Soc Trans (1978) 0.89

Captopril(SQ 14,225): in vitro and in vivo influence on the proliferative response of rat lymphocytes. Experientia (1982) 0.89

Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells. Steroids (2001) 0.89

Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp Cell Res (2000) 0.88

Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid. Biochem J (1985) 0.88

Rat testicular carboxylesterase: cloning, cellular localization, and relationship to liver hydrolase A. Arch Biochem Biophys (1995) 0.87